AIM IMMUNOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AIM IMMUNOTECH INC. (AIM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-08-14
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 0.00 shares.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 0.00 shares.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 400.00K shares.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 247.92K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 0.00 shares 10-Q · filed 2024-08-14 | |||||||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | ||||||||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-08-14 | 0.00 shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 0.00 shares 10-Q · filed 2024-08-14 | |||||||
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | ||||||||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 150.00K shares derived: sum of 2 quarters · filed 2023-11-14 | 300.00K shares 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 300.00K shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 150.00K shares 10-Q · filed 2023-05-15 | 300.00K shares 10-Q · filed 2022-05-13 | |||||||
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 0.00 shares 10-Q · filed 2022-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 0.00 shares 10-Q · filed 2022-08-15 | 0.00 shares derived: sum of 3 quarters · filed 2022-08-15 | 400.00K shares derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2022-05-13 | 400.00K shares derived: sum of 3 quarters · filed 2022-05-13 | 400.00K shares derived: sum of 4 quarters · filed 2022-05-13 | |||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 400.00K shares derived: sum of 2 quarters · filed 2021-03-31 | 400.00K shares derived: sum of 3 quarters · filed 2021-03-31 | 400.00K shares 10-K · filed 2021-03-31 | |||||
| 2020-09-30 | 400.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 400.00K shares derived: sum of 2 quarters · filed 2020-11-12 | 400.00K shares 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 0.00 shares 10-Q · filed 2020-08-14 | |||||||
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 | ||||||||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-12 | 39.27K shares 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 39.27K shares 10-Q · filed 2020-08-14 | |||||||
| 2019-03-31 | 39.27K shares 10-Q · filed 2020-05-14 | 1.73M shares 10-Q · filed 2019-05-15 | |||||||
| 2018-09-30 | 8.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -1.26M shares derived: sum of 2 quarters · filed 2019-11-14 | 75.52K shares 10-Q · filed 2019-11-14 | 4.68M shares 10-Q · filed 2018-11-14 | |||||
| 2018-07-31 | 2.23K shares 10-K · filed 2020-03-30 | 98.10K shares 10-Q · filed 2018-11-14 | |||||||
| 2018-06-30 | -1.27M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 66.67K shares 10-Q · filed 2019-08-14 | 2.93M shares 10-Q · filed 2018-08-14 | ||||||
| 2018-03-31 | 1.34M shares 10-Q · filed 2019-05-15 | ||||||||
| 2017-09-30 | 671.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 1.34M shares 10-Q · filed 2018-11-14 | |||||||
| 2017-06-30 | 669.62K shares 10-Q · filed 2018-08-14 | ||||||||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -1.98M shares derived: sum of 2 quarters · filed 2018-03-30 | 247.92K shares 10-K · filed 2018-03-30 | ||||||
| 2016-09-30 | -1.98M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 247.92K shares 10-Q · filed 2016-11-14 | |||||||
| 2016-06-30 | 2.23M shares 10-Q · filed 2016-08-15 | ||||||||
| 2015-09-30 | -733.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 66.67K shares 10-Q · filed 2016-11-14 | |||||||
| 2015-06-30 | 800.00K shares 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |